Measurements of the lightest hypernucleus (HΛ3): progress and perspective.

Sci Bull (Beijing)

Brookhaven National Laboratory, Upton NY 11973, USA. Electronic address:

Published: December 2023

The hyperon-nucleon (Y-N) interaction is important for the description of the equation-of-state of high baryon density matter. Hypernuclei, the cluster object of nucleons and hyperons, serve as cornerstones of a full understanding of the Y-N interaction. Recent measurements of the lightest known hypernucleus, the hypertriton's (HΛ3) and anti-hypertriton's (H¯Λ¯3) lifetime, mass and Λ separation energy have attracted interests on the subject. Its cross section and collective flow parameters have also been measured in heavy-ion collisions, which have revealed new features on its production mechanism. In this article we summarise recent measurements of HΛ3, focusing on the heavy-ion collisions. We will discuss their implications for the HΛ3 properties and the constrains on the Y-N interaction models.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scib.2023.11.045DOI Listing

Publication Analysis

Top Keywords

y-n interaction
12
measurements lightest
8
lightest hypernucleus
8
heavy-ion collisions
8
hΛ3
4
hypernucleus hΛ3
4
hΛ3 progress
4
progress perspective
4
perspective hyperon-nucleon
4
hyperon-nucleon y-n
4

Similar Publications

Background: Plasma NT-proBNP (N-terminal pro-B-type natriuretic peptide) is commonly used to diagnose heart failure with preserved ejection fraction (HFpEF), but its diagnostic performance in the ambulatory/outpatient setting is unknown because previous studies lacked objective reference standards.

Methods: Among patients with chronic dyspnea, diagnosis of HFpEF or noncardiac dyspnea was determined conclusively by exercise catheterization in a derivation cohort (n=414), multicenter validation cohort 1 (n=560), validation cohort 2 (n=207), and a nonobese Japanese validation cohort 3 (n=77). Optimal NT-proBNP cut points for HFpEF rule out (optimizing sensitivity) and rule in (optimizing specificity) were derived and tested, stratified by obesity and atrial fibrillation.

View Article and Find Full Text PDF

Metabolic-dysfunction-associated steatotic liver disease (MASLD) is a progressive liver disorder that possesses metabolic dysfunction and shows steatohepatitis. Although the number of patients is globally increasing and many clinical studies have developed medicine for MASLD, most of the studies have failed due to low efficacy. One reason for this failure is the lack of appropriate animal disease models that reflect human MASLD to evaluate the potency of candidate drugs.

View Article and Find Full Text PDF

Vascular Ehlers-Danlos syndrome (vEDS) arises from mutations in collagen-III, a major structural component of the extracellular matrix (ECM) in vascularized tissues, including blood vessels. Fibrillar collagens form a triple-helix that is characterized by a canonical (Gly-X-Y) sequence. The substitution of another amino acid for Gly within this conserved repeating sequence is associated with several hereditary connective tissue disorders, including vEDS.

View Article and Find Full Text PDF

SGK1-Mediated Vascular Smooth Muscle Cell Phenotypic Transformation Promotes Thoracic Aortic Dissection Progression.

Arterioscler Thromb Vasc Biol

February 2025

Department of Cardiac Surgery (S.L., H.L., P.Z., Z.D., B.S., S.X., Y.N., X.T., L.Z., H.W., N.L., F.Z., W.Y.), Central Hospital Affiliated to Shandong First Medical University, Jinan, China.

Background: The occurrence of thoracic aortic dissection (TAD) is closely related to the transformation of vascular smooth muscle cells (VSMCs) from a contractile to a synthetic phenotype. The role of SGK1 (serum- and glucocorticoid-regulated kinase 1) in VSMC phenotypic transformation and TAD occurrence is unclear.

Methods: Four-week-old male Sgk1 ( floxed) and Sgk1;Tagln (smooth muscle cell-specific knockout) mice were administered β-aminopropionitrile monofumarate for 4 weeks to model TAD.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the interaction between Ang-(1-7) and the ET-1 system in the context of pulmonary hypertension, suggesting that Ang-(1-7) opposes harmful effects of ET-1.
  • Research methods include various models (in vivo in mice, ex vivo in isolated arteries, and in vitro in human cells) that demonstrate Ang-(1-7) treatment reduces pulmonary vascular damage and promotes vasodilation.
  • Findings reveal a complex signaling network involving MasR and ETR that protects against vascular injury, highlighting the potential for enhancing this pathway to improve vascular health.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!